1. Home
  2. CREG vs RGNT Comparison

CREG vs RGNT Comparison

Compare CREG & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CREG

Smart Powerr Corp.

HOLD

Current Price

$0.55

Market Cap

18.4M

Sector

Utilities

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$2.87

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CREG
RGNT
Founded
N/A
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
20.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CREG
RGNT
Price
$0.55
$2.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.5M
3.1K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$262,509.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$2.73
52 Week High
$2.66
$8.35

Technical Indicators

Market Signals
Indicator
CREG
RGNT
Relative Strength Index (RSI) 44.75 35.85
Support Level $0.19 $2.80
Resistance Level $1.37 $3.35
Average True Range (ATR) 0.13 0.16
MACD 0.03 0.02
Stochastic Oscillator 16.68 28.83

Price Performance

Historical Comparison
CREG
RGNT

About CREG Smart Powerr Corp.

Smart Powerr Corp is engaged in waste energy recycling and is a developer of energy efficiency solutions for various energy intensive industries in China. It uses Build-Operate-Transfer (BOT) model to provide energy saving and recovery facilities for multiple energy intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. It provides a clean-technology and energy-efficient solution aimed at reducing the air pollution and energy shortage problems in China. The company's operations are conducted in one industry segment. All of its assets are located in the PRC.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: